Overview
- Screening among adults aged 45–49 rose from about 20% in 2019 to 33.7% in 2023 without any drop in older-adult access.
- Local-stage colorectal cancer incidence in the 45–49 cohort jumped 50% from 9.4 cases per 100,000 in 2019 to 17.5 per 100,000 in 2022, driven by first-time screenings.
- A randomized trial published in JAMA found unsolicited mailed FIT kits achieved a 26.2% uptake compared with 14.5%–17.4% for active-choice outreach strategies.
- Increases in screening have been concentrated among highly educated and insured individuals, raising warnings about widening health disparities.
- Researchers emphasize the need for implementation studies to assess long-term mortality impacts and to optimize outreach for under‐served populations.